These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 22959595)

  • 1. Exosomes for drug delivery - a novel application for the mesenchymal stem cell.
    Lai RC; Yeo RW; Tan KH; Lim SK
    Biotechnol Adv; 2013; 31(5):543-51. PubMed ID: 22959595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery.
    Yeo RW; Lai RC; Zhang B; Tan SS; Yin Y; Teh BJ; Lim SK
    Adv Drug Deliv Rev; 2013 Mar; 65(3):336-41. PubMed ID: 22780955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets?
    Millard SM; Fisk NM
    Bioessays; 2013 Mar; 35(3):173-82. PubMed ID: 23184477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of mesenchymal stem cell-derived microvesicles.
    Biancone L; Bruno S; Deregibus MC; Tetta C; Camussi G
    Nephrol Dial Transplant; 2012 Aug; 27(8):3037-42. PubMed ID: 22851627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles.
    Katsuda T; Kosaka N; Takeshita F; Ochiya T
    Proteomics; 2013 May; 13(10-11):1637-53. PubMed ID: 23335344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes as a potential tool for a specific delivery of functional molecules.
    Nazarenko I; Rupp AK; Altevogt P
    Methods Mol Biol; 2013; 1049():495-511. PubMed ID: 23913240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation.
    Lai RC; Yeo RW; Tan KH; Lim SK
    Regen Med; 2013 Mar; 8(2):197-209. PubMed ID: 23477399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration.
    Shimbo K; Miyaki S; Ishitobi H; Kato Y; Kubo T; Shimose S; Ochi M
    Biochem Biophys Res Commun; 2014 Mar; 445(2):381-7. PubMed ID: 24525123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of Small Interfering RNAs to Cells via Exosomes.
    Wahlgren J; Statello L; Skogberg G; Telemo E; Valadi H
    Methods Mol Biol; 2016; 1364():105-25. PubMed ID: 26472446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal Stem Cell-Derived Exosomes as Drug Delivery Vehicles in Disease Therapy.
    Zhao W; Li K; Li L; Wang R; Lei Y; Yang H; Sun L
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cell (MSC)-derived exosomes as a cell-free therapy for patients Infected with COVID-19: Real opportunities and range of promises.
    Rezakhani L; Kelishadrokhi AF; Soleimanizadeh A; Rahmati S
    Chem Phys Lipids; 2021 Jan; 234():105009. PubMed ID: 33189639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cell exosomes.
    Lai RC; Yeo RW; Lim SK
    Semin Cell Dev Biol; 2015 Apr; 40():82-8. PubMed ID: 25765629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and Characterization of Exosome from Human Embryonic Stem Cell-Derived C-Myc-Immortalized Mesenchymal Stem Cells.
    Lai RC; Yeo RW; Padmanabhan J; Choo A; de Kleijn DP; Lim SK
    Methods Mol Biol; 2016; 1416():477-94. PubMed ID: 27236691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic profiling of exosomes: current perspectives.
    Simpson RJ; Jensen SS; Lim JW
    Proteomics; 2008 Oct; 8(19):4083-99. PubMed ID: 18780348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches to lupus drug discovery using stem cell therapy. Role of mesenchymal-stem-cell-secreted factors.
    Figueroa FE; Cuenca Moreno J; La Cava A
    Expert Opin Drug Discov; 2014 May; 9(5):555-66. PubMed ID: 24655067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA.
    Lu M; Zhao X; Xing H; Xun Z; Zhu S; Lang L; Yang T; Cai C; Wang D; Ding P
    Int J Pharm; 2018 Oct; 550(1-2):100-113. PubMed ID: 30138707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application.
    Yamashita T; Takahashi Y; Takakura Y
    Biol Pharm Bull; 2018; 41(6):835-842. PubMed ID: 29863072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases.
    Xitong D; Xiaorong Z
    Gene; 2016 Jan; 575(2 Pt 2):377-384. PubMed ID: 26341056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functions and application of exosomes.
    Qin J; Xu Q
    Acta Pol Pharm; 2014; 71(4):537-43. PubMed ID: 25272880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.
    Johnsen KB; Gudbergsson JM; Skov MN; Pilgaard L; Moos T; Duroux M
    Biochim Biophys Acta; 2014 Aug; 1846(1):75-87. PubMed ID: 24747178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.